We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SBUX:NASDAQStarbucks Corporation Analysis

Data as of 2026-06-07 - not real-time

$95.29

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Starbucks is trading just above its near‑term support of $93.64 with the 20‑day SMA ($102.20) comfortably above the 50‑day SMA ($99.59) and the 200‑day SMA ($91.36), signalling a bullish long‑term trend. However, the 14‑day RSI sits at 33, indicating the stock is oversold, while the MACD line remains below its signal, a bearish short‑term cue. Volume is on the rise and the beta of 0.73 suggests lower market‑wide volatility, yet the 30‑day price volatility exceeds 30%, reflecting heightened price swings. The valuation metrics are stark: a trailing P/E of 73 and a DCF‑derived fair value of roughly $31 place the current price of $95.29 in the overvalued zone.
Fundamentally, revenue grew 8.8% YoY and operating margins are modest at 8.4%, but free cash flow is negative and debt sits at $24.4 B with a negative book value per share, eroding balance‑sheet strength. The dividend yield of 2.6% looks attractive but the payout ratio of 188% is unsustainable. Recent news of AI inventory tool glitches and corporate layoffs underscores operational challenges and cost‑cutting efforts, while the CEO’s participation in a consumer‑retail conference and a lean drive‑thru expansion signal continued strategic focus. Analyst consensus remains a “Buy” with a median price target of $110, implying modest upside despite the current overvaluation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above technical support
  • Bearish MACD signal despite bullish SMA crossover
  • Elevated 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of ~9% with ongoing drive‑thru expansion
  • Cost‑reduction initiatives including layoffs and office closures
  • Analyst price targets averaging $106‑$110

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong global brand and franchise network
  • Potential for international market penetration
  • Long‑term dividend yield despite current sustainability concerns

Key Metrics & Analysis

Financial Health

Revenue Growth8.80%
Profit Margin3.89%
P/E Ratio72.7
ROA7.38%
P/B Ratio-12.8
Op. Cash Flow$4.3B
Free Cash Flow$-1304087552

Technical Analysis

TrendBullish
RSI33.4
Support$93.64
Resistance$108.88
MA 20$102.20
MA 50$99.59
MA 200$91.36
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

Fair Value$31.24
Target Price$106.25
Upside/Downside11.50%
GradeOvervalued
TypeBlend
Dividend Yield2.60%

Risk Assessment

Beta0.73
Volatility30.02%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.